Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy

Author： Yhim Ho-Young   Cho Sang-Hee   Kim Sam Yong   Cho In Sung   Lee Kyu Taek   Lee Won Sup   Lee Soon Il   Park Moo Rim   Park Sang-Gon   Han Hye-Suk   Choi Yoon Seok   Chung Ik-Joo   Shim Hyun-Jeong   Lee Na-Ri   Song Eun-Kee   Kim Hee Sun   Yim Chang-Yeol  

Publisher： Spandidos Publications

E-ISSN： 1791-2431|34|1|155-164

ISSN： 1021-335X

Source： Oncology Reports, Vol.34, Iss.1, 2015-07, pp. : 155-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients

By                        

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2385-2398

Spandidos Publications

Access to resources Recommend Favorite

DNA Repair Gene and MTHFR Gene Polymorphisms as Prognostic Markers in Locally Advanced Adenocarcinoma of the Esophagus or Stomach Treated with Cisplatin and 5-Fluorouracil-Based Neoadjuvant Chemotherapy

By Ott Katja  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2688-2698

Springer Publishing Company

Access to resources Recommend Favorite

Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?

By Marcuello E.   Altés A.   Menoyo A.   Rio E.   Baiget M.  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 835-840

Springer Publishing Company

Access to resources Recommend Favorite

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

By                    

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 247-251

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced nonsmall cell lung cancer patients treated with pemetrexedbased chemotherapy

By                      

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1165-1170

Spandidos Publications

Access to resources Recommend Favorite